Generics Seek New Prescription for Influence
By Bennett Roth
Roll Call Staff
Roll Call Staff
Oct. 14, 2009, 12 a.m.
The generic drug industry, outmanned and outspent on the lobbying front compared to its name-brand counterparts, has been struggling to be heard on Capitol Hill throughout the health care debate.
LOG IN
NOT A SUBSCRIBER
Forget your password? Click here or
Call 202-824-6800
Subscribe to Print and/or Online
Click Here
Hill Users have Free access,
click Here to register.
Schumer Advocates for Many on Panel
Nov. 16, 12 a.m.
As Senate Majority Leader, Lyndon Johnson once said of the Joint Economic Committee, “It’s as useless as tits on a bull.” But as that panel’s chairman during the 110th Congress, Sen. Charles Schumer (D-N.Y.) seized the opportunity to elevate the traditionally low-profile post to the forefront of shaping policy. Read Full Article
Roll Call Video Channels
